We service over 1,400 Ophthalmologists with ImprimisRx compounded formulations prescribed for ophthalmic use.
Keep It Simple
Provide fewer drops at a lower cost with our proprietary topical ophthalmic compounded formulations* for patients following LASIK, PRK, cataract, and other ocular surgeries (and non-surgical applications).
Our formulations are enabled by our patented SSP Technology®, which allows active pharmaceutical ingredients (APIs) that ordinarily do not mix to solubilize into a predictable, well-distributed, micronized particle suspension.
Combination drop therapy® may reduce the number of eye drops needed after ocular surgery.
Commonly reported patient compliance issues after ocular surgery.1,2
- Daily dose frequency
- Inconsistent amount of drops used
- Instillation technique
- High cost to patients
Combination Drop Therapy Formulations
(Prednisolone acetate and gatifloxacin)
(Prednisolone acetate and nepafenac)
- PRED-GATI-BROMTM* or Triple DropTM
(Prednisolone acetate, gatifloxacin, bromfenac)
LessDrops Formulations from ImprimisRx
- Quality sterile compounded medications for pre and post ocular surgery
- Invented by ophthalmologists and pharmacists for unmet medical needs
- Patented Surfactant Solubilizing Process (SSP) technology that uniquely allows for the combination of drugs
This approach may alleviate the need for multiple postoperative drops and, in turn, helps cut medication costs. Developed with your patients top-of-mind, our proprietary topical compounded formulations aim to improve patient compliance and alleviate patient confusion with fewer drops, meaning they will be better able to follow the regimen you prescribe.